FORMULATION FOR ORAL ADMINISTRATION CONTAINING MESALAZINE

摘要

The present invention relates to a formulation containing Mesalazine in a stable form, obtained by coating the starting core with a first membrane in non-aqueous solution; said core containing Mesalazine at a high concentration, greater than 90%, obtained by producing starting cores with Active Substance content greater than 97%. The formulation according to the present invention containing Mesalazine with specific release in the colon; in particular the capsule formulation containing 500 mg of Mesalazine with specific release in the colon.